CASI Pharmaceuticals, Inc. (CASIF): Share Repurchases

Annual figures by period end, from SEC filings.

Older than the company's other figures. The latest Share Repurchases is for the year ended 2023-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.

$278.0K
Year ended 2023-12-31
$3.27M2022-12-31: $3.27M2023-12-31: $278.0K$278.0K
2022-12-31 Share Repurchases (USD) 2023-12-31
Period endedShare RepurchasesChange YoYSource filing
2023-12-31$278.0K-91.5%2026-05-15, From 2023-01-01
2022-12-31$3.27Mn/a2025-03-31, From 2022-01-01